Purpose of review Calcium crystals exist in both pathological and normal articular cartilage. The prevalence of these crystals dramatically increases with age, and crystals are typically found in osteoarthritic cartilage and synovial fluid. Relatively few studies have examined the effects of crystals on cartilage biomechanics or chondrocyte mechanotransduction. The purpose of this review is to describe how crystals could influence cartilage biomechanics and mechanotransduction in osteoarthritis.
INTRODUCTION
Calcium pyrophosphate (PPi) dihydrate (CPPD) and basic calcium phosphate (Pi) (BCP) are crystals associated with disease in human joints. There is a clear association between these calcium-containing crystals and osteoarthritis, with most studies reporting calcium crystals in 40-70% of osteoarthritis cases [1] [2] [3] . Although studies agree that calciumcrystals are prevalent in a significant portion of osteoarthritis cases, the clinical implications remain controversial. Some studies report that patients with chondrocalcinosis have an increased rate and severity of radiographic osteoarthritis and greater disability if CPPD crystals are also present in the synovial fluid [4] [5] [6] . Other studies find that osteoarthritis patients with BCP crystals have more severe radiographic osteoarthritis than those lacking crystals [1, 2, 7] . Osteoarthritis patients with CPPD in their synovial fluid (SF) are also more likely to be symptomatic than asymptomatic [8] . In summary, there is clear evidence that calcium crystal depositions contribute to the pathogenesis of osteoarthritis, yet the mechanism(s) remain unclear.
Although progress is being made in understanding crystal deposition, crystal prevalence, and treatment of crystal diseases, the implications of mechanical loads on crystal deposition and crystal-induced effects on chondrocyte mechanotransduction have yet to be resolved. The purpose of this review is to summarize current knowledge regarding the mechanobiological implications of crystals in articular cartilage.
Joints are responsible for transmitting mechanical forces that arise from skeletal function and during human movement. For example, in the hip joint, contact forces can be more than seven times body weight [9, 10] . In a given joint these loads result in articular cartilage with both severe loadrelated deterioration and minimal deterioration associated with the absence of load [11] . For almost 3 decades, we have known that chondrocyte metabolism is regulated at least in part by the mechanical loads transmitted through joints [12] . Given that altered joint loading and dysregulated chondrocyte mechanotransduction are associated with osteoarthritis [13, 14] , the following questions arise: do mechanics play a role in crystal deposition? Do crystals alter chondrocyte mechanotransduction?
Cartilage is a soft material with spatially varying material properties. The extracellular matrix (ECM) comprises about 90% of the tissue volume and has a stiffness of $1000 kPa [15, 16] . The pericellular matrix (PCM) surrounding chondrocytes is even softer with a stiffness of about 150 kPa [15, 17] , and the chondrocytes are the least stiff around 0.1 kPa [18] . We were unable to find published literature documenting the stiffness of CPPD or BCP crystals. However, advances in crystallographic analysis of synthetic CPPD crystals find monoclinic symmetry [19, 20 & ] which typically results in stiffness in the gigapascal range [21] . Therefore, it is likely that the stiffness of crystals is orders of magnitude greater than the local tissue environment of articular cartilage. As the relatively stiff crystals occur on the periphery of the relatively soft chondrocyte, aging-induced crystal formation may induce aberrant mechanotransduction in chondrocytes (Fig. 1 ). The dramatic difference between the stiffness of the crystals and the stiffness of cartilage components (ECM, PCM, and chondrocytes) may provide a mechanism for crystals to alter chondrocyte mechanotransduction. FIGURE 1. Conceptual model of how the presence of basic calcium phosphate and calcium pyrophosphate dihydrate crystals may alter mechanotransduction in the aging chondrocyte. Crystal prevalence increases with aging, and crystals are formed from articular cartilage vesicles on the chondrocyte periphery. In osteoarthritis, the stiffness of the extracellular matrix and pericellular matrix decreases. As crystals are substantially stiffer, they may promote dysregulated chondrocyte mechanotransduction in osteoarthritis.
ARTICULAR CARTILAGE VESICLES ARE SECRETED BY CHONDROCYTES AND FORM CRYSTALS
regulated by the ratio of PPi to Pi with increased PPi promoting CPPD formation [23, 24] . CPPD crystals are formed from ACVs through ATP usage, whereas BCP crystals are formed predominately with betaglycerophosphate [25, 26] .
Understanding how the balance between PPi and Pi affects crystal formation may lead to new strategies to reduce crystal prevalence and disease symptoms. PPi/Pi levels are regulated by ectoenzyme metabolism of ATP on the surface of ACVs and through the ratio of nucleotide triphosphate PPi hydrolase to alkaline phosphatase enzyme activities [23, 27] . Other work has shown a phosphoethanolamine/phosphocholine phosphatase PHOSPHO1 and IL-1b as key players in altered PPi/Pi ratios. PHOSPHO1 is a phosphoethanolamine/phosphocholine phosphatase that draws Pi into the ACV to begin mineralization [28] . IL-1b treated mesenchymal cells produce vesicles with less PPi and altered ENPP1 (ectonucleoside pyrophosphaohydrolase/phosphodiesterase 1) to alkaline phosphatase levels suggesting that inflammatory cytokines may trigger mineralization [29] . Proprotein convertase 1, a RDNP family gene expressed in chrondrocytes, has been studied extensively by Terkeltaub et al. [30, 31] who demonstrated its role in directly regulating extracellular PPi and indirectly regulating intracellular PPi through regulation of NTPPH. Fuerst et al. [32, 33] found a correlation between ACV mineralization and type X collagen, an indicator of cell hypertrophy, using histological analysis and digital-contact radiography in osteoarthritis knees. These studies also identified a correlation between in-vivo mineralization progression and the ability of chondrocytes to produce BCPs in vitro. In-vitro chondrocyte hypertrophy led to mineralization of the ECM.
OSTEOARTHRITIS AND CARTILAGE MINERALIZATION
Healthy human articular cartilage is primarily composed of type II collagen and large proteoglycans, such as aggrecan. Jubeck et al. [26] demonstrated that changes in cartilage ECM proteins consistent with osteoarthritis matrix changes correlate to ACV mineralization. Including both type II collagen and large proteoglycans in the ECM of chondrocyte agarose gel constructs inhibited ACV mineralization. In contrast to healthy cartilage, osteoarthritis cartilage has decreased type II collagen, fewer large proteoglycans, and increased type I collagen. The addition of type I collagen to chondrocyte agarose constructs containing type II collagen showed increased ACV mineralization suggesting a release of an inhibitory factor in type II collagen. Therefore, small quantities of type I collagen, decreases in type II collagen, and loss of large proteoglycans found pathologically in osteoarthritic cartilage may promote both CPPD and BCP crystal formation. These studies provide a link between osteoarthritis and cartilage mineralization.
The findings of Jubeck et al. highlight the importance of ECM proteins in crystal formation. In a later study, this group compared collagen and collagen receptors on ACVs in human and porcine to explain the differences in mineralization behavior [34] . They found isolated human ACVs to have increased type II collagen not found in porcine ACVs. Further, they suggest that isolated human ACVs result in poor mineralization largely due to residual type II collagen from sample preparation. Proteomic analysis of ACVs showed similarities and differences between normal and osteoarthritic cartilage with the differing proteins primarily consisting of ECM proteins in osteoarthritic cartilage [35] . These studies emphasize the importance of tissue type, species, and sample preparation when studying mineralization due to changes in ECM proteins.
It remains unknown whether collagen is bound to ACVs through receptors or specific structural proteins. However, the presence of collagen could anchor the ACV onto the ECM or PCM. Alternatively, the collagen profile of an ACV may identify the composition of the parent cell and/or signal matrix composition changes to the ACV [34] . This could provide a mechanism for transmitting extracellular mechanical loading to chondrocytes for mechanotransduction.
JOINT CRYSTALS ARE ASSOCIATED WITH DISEASE
Given that only some of the articular cartilage in a joint is load-bearing, early studies attempted to elucidate the spatial distribution of crystals in cartilage to determine if there's an association between crystal location and mechanical stress. In 1983, cuboid crystals were found almost exclusively in the superficial zone of structurally normal femoral head cartilage [36] . In 1990, Stockwell [37] found that crystal density was highest 0-50 nm from the articular surface compared with 50-500 nm from the articular surface regardless of cell proximity. However, crystal content was higher in regions surrounding cell debris. A follow-up study focused on the superficial zone and found that a band of microcrystals existed 10-20 mm below the articular surface [38] . In addition, crystals density was higher in superior (e.g., loaded) samples than inferior samples of femoral head cartilage. Given that superior cartilage regions experience higher mechanical stress [10, 11] , this suggests that mechanical loading may be implicated in crystal formation. However, a more recent study revisited the spatial distribution of crystals in osteoarthritic articular cartilage with more sensitive methods and found that crystal content did not differ between superficial and deep layers, or between femoral compartments [39] . In summary, crystals are found in both nonweight-bearing and weight-bearing regions of articular cartilage and throughout the depth of the tissue.
Studies show a clear association between these calcium-containing crystals and osteoarthritis, with most studies reporting calcium crystals in 40-70% of osteoarthritis cases [1] [2] [3] . Recent studies using advanced methods report lower coexistence of CPP crystals and osteoarthritis, with coexistence in 22.3% of patients in Oliviero et al. Table 1 ). Interestingly, in Olivero et al. the analysis of osteoarthritis SF revealed that age and inflammatory indices were significantly higher in SF positive for CPP crystals compared with those without crystals.
Another study investigated the prevalence of CPPD crystals in patients of Thai descent with osteoarthritis (n ¼ 100). This study found that 43% of patients had CPP crystals, 35% had chondrocalcinosis, and 25% had both CPPD and chondrocalcinosis [40] . The average age at joint replacement was significantly higher for patients with crystals. This study also found no significant difference in function (e.g., standing from a sit, stair climbing, etc.) between osteoarthritis patients with CPPD and osteoarthritis patients without CPPD crystals. Thus, mechanical stress in osteoarthritis patients in the presence of crystals did not inhibit their ability to accomplish basic daily activities. This finding may be limited to the patient population in this study, as other reports typically find worse symptoms, disability, and radiographic progression in CPPD disease than in osteoarthritis [5, 8, 44] . Furthermore, this finding may be specific to CPPD crystals given that BCP is also present in osteoarthritis joints and associated with rapid progression of radiographic osteoarthritis [1, 3, 7, 32, 45] .
CHONDROCYTE LOADING, MECHANICAL STRESS, AND MECHANOTRANSDUCTION
To our knowledge, only a single study directly tested the effect of mechanical stress on articular cartilage crystals. Given that clinicians prescribe rest to minimize the mechanical stress on joints to manage acute arthritis, Agudelo et al. [46] studied the effects of joint motion on crystal-induced articular inflammation. Canine knee joints were injected with monosodium urate crystals and exercised with 90 degrees of flexion-extension for various durations. Exercise increased the inflammatory response in proportion to the duration of joint motion. Higher leukocyte counts, increased polymorphonuclear leukocyte infiltration, larger effusions, and increased clearance of intravenously injected isotopes from synovial vessels evinced this increased inflammatory response. In contrast, control joints not injected with crystals were grossly normal, with the exception of dilated vessels in the exercised joints. Thus, joint loading and associated mechanical stress can worsen the negative biological response to crystals in joints (Fig. 1) . Articular chondrocytes are subject to nearly continual mechanical loading. Cyclical load-bearing is important for joint health as demonstrated by the marked hindlimb glycosaminoglycan loss that occurs following tail suspension in rats [47] . Matrix metabolism is substantially altered by dynamic compression, but the balance between matrix synthesis and degradation is unclear as demonstrated by findings of both induced matrix transcription and synthesis [48, 49] and transcription and increased activity of the catabolic enzymes matrix metalloproteinases (MMP) MMP-3, MMP-9, MMP-13, and ADAMTS-4 and ADAMTS-5 [50] . Dynamic compression can induce phosphorylation of multiple enzymes including mitogen activated protein kinase and, receptor tyrosine kinase, SEK, [51, 52] , Akt [53] , Erk-1 and Erk-2 [54] [55] [56] , and Rho kinase [57] . These results originate from varying invitro models. However, taken together some trends emerge as follows: low-magnitude cyclical loading usually results in biological changes promoting matrix synthesis, and high magnitude cyclical or static loading typically yields changes that result in matrix catabolism. Future studies may examine the both role of crystals in chondrocyte mechanotransduction and the role of mechanical loading in crystal deposition.
CONCLUSION
CPPD and BCP are crystals that occur in articular cartilage and synovial fluid and are associated with joint diseases such as osteoarthritis. These crystals are formed from ACVs that are secreted from chondrocytes. CPPD and BCP crystal deposition occurs in both load-bearing and noncontacting areas of articular cartilage. The dramatic difference between the crystal stiffness and the stiffness of other cartilage components (ECM, PCM, and chondrocytes) may provide a mechanism by which crystals alter chondrocyte mechanotransduction (Fig. 1) . Further research is required to test this hypothesis, but it is supported by early observations that the combination of joint loading and exogenous crystals result in severe inflammation [46] . 
